@article{ATM27669,
author = {Li Zhang and Yi Wei and Xiaowei Yan and Na Li and Haolan Song and Li Yang and Yang Wu and Yu-Feng Xi and Hua-Wei Weng and Jian-Hua Li and Edward H. Lin and Li-Qun Zou},
title = {Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma},
journal = {Annals of Translational Medicine},
volume = {7},
number = {14},
year = {2019},
keywords = {},
abstract = {Background: The relationship between survivin and extranodal, nasal-type natural killer/T cell lymphoma (ENKTCL) was unclearly established yet. We here studied the potential prognostic roles of survivin and its implication as a target in ENKTCL therapy.
Methods: ENKTCL patients’ peripheral blood were collected and tested by ELISA. ENKTCL cell lines were cultured with or without survivin inhibitor and tested by MTT and Flow cytometry. According to the gene expression profiles from the ArrayExpress Archive under E-TABM-702, survivin co-regulated cluster was established by Coupled Two-way Clustering Algorithm.
Results: Seventeen point six percent of total 17 ENKTCL patients were serum survivin-positive. These patients had poorer outcome than that of negative cases (P},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/27669}
}